| Brand Name | Osikin |
| Packaging Type | Strip |
| Molecule | Osimertinib |
| Generic Name | Osimertinib 80mg |
| Manufactured By | Ziska Pharmaceuticals Ltd. |
| Quantity | 10 Tablets |
| Form | Tablet |
| Country of Origin | Bangladesh |
| Categories | Oncology |
Introduction to Osikin 80mg Tablets
Osikin 80mg Tablet is Manufactured by Ziska Pharmaceuticals Ltd. It is an anti-cancer drug with a key component Osimertinib, which is a potent EGFR tyrosine kinase inhibitor. It is used to manage non-small cell lung cancer (NSCLC) in patients with specific mutations in the epidermal growth factor receptor (EGFR), such as the T790M mutation, which often causes resistance to prior therapies.
Osikin Osimertinib 80mg works by targeting and inhibiting the abnormal EGFR proteins that fuel cancer cell growth, making it an effective option for treating advanced stages of NSCLC. It is frequently prescribed as a first-line treatment or for patients whose cancer has become invulnerable to earlier treatments. Patients should follow their doctor's instructions for proper use.